Global In Vitro Toxicology Testing Market Forecast up to 2024
- September, 2018
- Domain: Healthcare - Diagnostics
Pages:
112
Tables:
15
Charts:
39
Regions/Countries:
0
Companies:
16
Enquiry Hours:
10
- Get Free 10% Customization in this Report
[112 Report Pages] This market research report identifies Laboratory Corporation of America Holdings, Charles River Laboratories, Inc, Thermo Fisher Scientific, Eurofins Scientific, Agilent Technologies, Inc., as the major vendors operating in the global in vitro toxicology testing market. This report also provides a detailed analysis of the market by toxicology end points (systemic toxicity, cytotoxicity testing, genotoxicity testing, ocular toxicity, organ toxicity, dermal toxicity, neurotoxicity, and others), industry type (pharmaceutical and biopharmaceutical, cosmetics, chemical, diagnostics, and food industry), and region (North America, Europe, Asia Pacific, and Rest of the World).
Overview of the In Vitro Toxicology Testing Market:
Infoholic’s market research report predicts that the global in vitro toxicology testing market will grow at a CAGR of 8.2% during the forecast period 2018–2024. The market for in vitro toxicology testing is driven by high opposition to animal testing, increased cost related to animal-based toxicity testing, and increasing R&D expenditure for early stage toxicity testing. Whereas, the lack of in vitro models and decreased adoption rate are limiting the growth of the in vitro toxicology testing market to an extent.
According to the in vitro toxicology testing market analysis, Europe accounted for the largest share of the global in vitro toxicology testing market followed by North America in 2017. The reason is the upsurge in the investments by the European Commission in R&D to develop substitute methods to in vitro testing is driving the demand in this region. Asia Pacific is expected to grow at a high CAGR during the forecast period due to increasing number of contract research organizations offering testing services, advancements in healthcare infrastructure, increasing investments in the biopharmaceutical sector, and upward economic conditions in the region.
Competitive Analysis and Key Vendors:
There is an increase in collaborations between companies on in vitro testing of compounds. For instance, in December 2016, Evotec and Celgene entered into a drug discovery collaboration for neurodegenerative diseases. According to agreement terms, Celgene will use Evotec’s unique induced pluripotent stem cell (iPSC) platform that enables systematic drug screening in patient-derived disease models. In June 2017, Censo Biotechnologies Ltd. collaborated with Evotec AG to source and provide patient-derived induced pluripotent stem cells to support Evotec’s drug discovery iPSC platform. In addition, the companies are also coming up with new products for in vitro testing. For instance, in January 2018, STEMCELL Technologies Inc. released two product lines for organoid research that will enable scientists to create powerful models for studying human disease in the laboratory.
Some of the In Vitro Toxicology Testing Market key vendors are:
- Laboratory Corporation of America Holdings
- Charles River Laboratories, Inc.
- Thermo Fisher Scientific
- Eurofins Scientific
- Agilent Technologies, Inc.
Other prominent vendors in the global in vitro toxicology testing market are Bio-Rad Laboratories, GE Healthcare, SGS SA, BioIVT, Abbott Laboratories, Gentronix Limited, Promega Corporation, MB Research Laboratories, Evotec AG (Cyprotex plc), Catalent, Inc., Qiagen N.V., and niche players.
In Vitro Toxicology Testing Market by Toxicology End Points:
- Systemic toxicity
- Cytotoxicity testing
- Genotoxicity testing
- Ocular toxicity
- Organ toxicity
- Dermal toxicity
- Neurotoxicity
- Others
In 2017, the systemic toxicity accounted for the highest market share due to the availability of a wide range of sub-studies, which ensure total analysis of toxicity and safety margin of the testing compounds.
In Vitro Toxicology Testing Market by Industry type:
- Pharmaceutical and biopharmaceutical industry
- Cosmetics industry
- Chemical industry
- Diagnostics industry
- Food industry
In 2017, the pharmaceutical and biopharmaceutical industry occupied significant market share and the cosmetics industry is expected to hold a high percentage during the forecast period. Increased support of regulatory authorities to use in vitro and in silico methods instead of animal testing to check toxicology is driving the growth of the cosmetic industry.
In Vitro Toxicology Testing Market Benefits:
The report provides detailed information about the services offered by in vitro toxicology testing in various therapeutic verticals and regions. With that, key stakeholders can find out the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to have an impact on market growth. Additionally, the report gives complete details about the business opportunities to key stakeholders to expand their business and capture revenues in the specific verticals. The report will help companies interested or established in this market to analyze the various aspects of this domain before investing or expanding their business in the in vitro toxicology testing market.
Key Stakeholders:
1 Industry Outlook
1.1 Industry Overview
1.2 Importance of Toxicology Studies
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Advantages of In Vitro Testing
3.3 Segmented Addressable Market
3.4 Trends in the In Vitro Toxicology Testing Market
3.5 Related Markets
3.5.1 In Vivo Toxicology
3.5.2 ADME Toxicology Testing
3.5.3 Biologics Safety Testing
4 Market Outlook
4.1 Market Segmentation
4.2 PEST Analysis
4.3 Porter 5(Five) Forces
5 Market Characteristics
5.1 DRO – Market Dynamics
5.1.1 Drivers
5.1.1.1 High opposition to animal testing
5.1.1.2 Low cost associated with in vitro toxicology testing
5.1.2 Opportunities
5.1.2.1 Advent of new in vitro models
5.1.2.2 Upsurge in toxicology database will facilitate the use of in vitro testing methods
5.1.3 Restraints
5.1.3.1 Barriers in adopting in vitro testing methods
5.1.3.2 Deficiency of in vitro models to conduct complex studies
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 Toxicity Endpoints: Market Size and Analysis
6.1 Overview
6.2 Systemic Toxicity Testing
6.3 Cytotoxicity Testing
6.4 Genotoxicity Testing
6.5 Organ Toxicity
6.6 Ocular Toxicity
6.7 Dermal Toxicity
6.8 Neurotoxicity
6.9 Others
7 Industry Type: Market Size and Analysis
7.1 Overview
7.2 Pharma and Biopharma Industry
7.3 Cosmetics Industry
7.4 Chemical Industry
7.5 Food Industry
7.6 Diagnostics Industry
8 Regions: Market Size and Analysis
8.1 Overview
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 Rest of the World
9 Competitive Landscape
9.1 Overview
10 Vendors Profile
10.1 Laboratory Corporation of America Holdings (LabCorp)
10.1.1 Overview
10.1.2 Business Units
10.1.3 Geographic Revenue
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategies
10.2 Charles River Laboratories, Inc.
10.2.1 Overview
10.2.2 Business Units
10.2.3 Geographic Revenue
10.2.4 Business Focus
10.2.5 SWOT Analysis
10.2.6 Business Strategies
10.3 Thermo Fisher Scientific, Inc.
10.3.1 Overview
10.3.2 Business Units
10.3.3 Geographic Revenue
10.3.4 Business Focus
10.3.5 SWOT analysis
10.3.6 Business Strategies
10.4 Eurofins Scientific
10.4.1 Overview
10.4.2 Geographic Revenue
10.4.3 Business focus
10.4.4 SWOT Analysis
10.4.5 Business Strategies
10.5 Agilent Technologies Inc.
10.5.1 Overview
10.5.2 Business Units
10.5.3 Geographic Revenue
10.5.4 Business Focus
10.5.5 SWOT Analysis
10.5.6 Business Strategies
11 Companies to Watch for
11.1 SGS SA
11.1.1 Overview
11.2 Abbott Laboratories
11.2.1 Overview
11.3 GE Healthcare
11.3.1 Overview
11.4 BioReliance Corporation (a subsidiary of Merck KGaA)
11.4.1 Overview
11.5 BioIVT
11.5.1 Overview
11.6 Bio-Rad Laboratories
11.6.1 Overview
11.7 Catalent, Inc.
11.7.1 Overview
11.8 Evotec AG (Cyprotex plc)
11.8.1 Overview
11.9 Gentronix Limited
11.9.1 Overview
11.10 Promega Corporation
11.10.1 Overview
11.11 Qiagen N.V.
11.11.1 Overview
Annexure
Abbreviations
TABLE 1 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION) 39
TABLE 2 OTHER PROMINENT VENDORS OF IN VITRO TOXICOLOGY TESTING MARKET 46
TABLE 3 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCT OFFERINGS 48
TABLE 4 CHARLES RIVER LABORATORIES, INC.: OFFERINGS 55
TABLE 5 THERMO FISHER SCIENTIFIC, INC.: PRODUCT OFFERINGS 63
TABLE 6 THERMO FISHER SCIENTIFIC, INC: RECENT DEVELOPMENTS 64
TABLE 7 EUROFINS SCIENTIFIC: PRODUCT OFFERINGS 71
TABLE 8 EUROFINS SCIENTIFIC: RECENT DEVELOPMENTS 71
TABLE 9 AGILENT TECHNOLOGIES INC: PRODUCT OFFERINGS 78
TABLE 10 AGILENT TECHNOLOGIES INC: RECENT DEVELOPMENTS 78
TABLE 11 SGS SA: SNAPSHOT 86
TABLE 12 SGS SA: RECENT DEVELOPMENTS 87
TABLE 1 ABBOTT LABORATORIES: SNAPSHOT 88
TABLE 2 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 88
TABLE 3 GE HEALTHCARE: SNAPSHOT 91
TABLE 4 GE HEALTHCARE: RECENT DEVELOPMENTS 91
TABLE 5 BIORELIANCE CORPORATION: SNAPSHOT 93
TABLE 6 BIORELIANCE CORPORATION: RECENT DEVELOPMENTS 94
TABLE 7 BIOIVT: SNAPSHOT 95
TABLE 8 BIOIVT: RECENT DEVELOPMENTS 95
TABLE 9 BIO-RAD LABORATORIES: SNAPSHOT 96
TABLE 10 CATALENT, INC.: SNAPSHOT 98
TABLE 11 EVOTEC AG: SNAPSHOT 100
TABLE 12 GENTRONIX LIMITED: SNAPSHOT 104
TABLE 13 PROMEGA CORPORATION: SNAPSHOT 105
TABLE 14 QIAGEN N.V.: SNAPSHOT 107
TABLE 15 QIAGEN N.V.: RECENT DEVELOPMENTS 107
Research Framework
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
- Forecasting
Market related information is congregated from both primary and secondary sources.
Primary sources
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.
